Item 5.02 - Executive Officer Departure: Julie Coletti, Executive Vice President and Chief Legal and Regulatory Officer of Align Technology, Inc., resigned from her position effective August 1, 2026, to join Illumina, Inc. as Chief Legal Officer. Filing Date and Reporting Period: This 8-K was filed on July 9, 2026, reporting an event that occurred on July 6, 2026. Company Information: The filing…

Our analysis rates this filing CAUTIOUS. The elevated concern level (6.8/10) reflects a material executive departure in a heavily regulated industry combined with an increasing risk trend and absence of disclosed succession planning. The departure of the Chief Legal and Regulatory Officer to a…

Concern level: HIGH (6.8/10). Key factors: High-severity executive departure (severity 7/10) - Chief Legal and Regulatory Officer resignation to competitor signals potential talent drain and loss of critical institutional knowledge in heavily regulated medical device sector; No disclosed succession plan or interim leadership identified - creates immediate governance and compliance gap during…

Notable risk changes: Chief Legal and Regulatory Officer departure to competitor (Illumina) - signals potential talent drain and loss of institutional legal/regulatory knowledge critical for FDA-regulated medical device company; No successor named or transition plan disclosed - creates governance vacuum in legal and regulatory functions during August 1 effective date; Executive moving to larger biotech competitor -…

The model predicts ALGN will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.